Skip Page Header

Home > Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor Lopinavir-Ritonavir.

Mulcahy, Fiona and Bergin, C and Boyle, Nicola and Barry, Michael and Clarke, Susan and Reynolds, Helen (2002) Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor Lopinavir-Ritonavir. Clinical Infectious Diseases, 34, (8), pp. 1143-1145.

[img]
Preview
PDF (Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor Lopinavir-Ritonavir) - Published Version
243kB

A study was designed to determine the interactions, both clinical and pharmacokinetic, between methadone and lopinavir-ritonavir. Results demonstrated a 36% reduction in the methadone area under the plasma concentration-time curve after the introduction of lopinavir-ritonavir, with no coincident symptoms of opioid withdrawal and no requirement for methadone dose adjustment.


Repository Staff Only: item control page